Showing results (121-130 of 168) with videos related to
Sort By:
Pageof 17
Epilepsy Research|August 1, 1990
A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsyJ W Sander, P N Patsalos, J R Oxley, et al.Epilepsy & Behavior Reports|October 26, 2021
The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workersJ Thorpe, S Ashby, J H Cross, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1994
The characteristics of epilepsy in a largely untreated population in rural EcuadorM Placencia, J W Sander, M Roman, et al.Neurology|September 7, 2011
Incidence of epilepsy: a systematic review and meta-analysisAnthony K Ngugi, S M Kariuki, C Bottomley, et al.Epilepsy Research|March 1, 1993
Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessmentM Placencia, J W Sander, S D Shorvon, et al.Acta Neurologica Scandinavica|September 16, 2015
Anti-epileptic drug changes and quality of life in the communityM Wassenaar, F S S Leijten, J W Sander, et al.Epilepsy Research|December 1, 1990
The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsyJ W Sander, P C Trevisol-Bittencourt, Y M Hart, et al.Seizure|March 1, 1994
Neuropsychological effects of tiagabine, a potential new antiepileptic drugS Sveinbjornsdottir, J W Sander, P N Patsalos, et al.Acta Neurologica Scandinavica|June 20, 2017
Electro-clinical criteria and surgical outcome: Is there a difference between mesial and lesional temporal lobe epilepsy?M Wassenaar, F S S Leijten, G-J de Haan, et al.European Journal of Neurology|September 18, 2018
Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factorsR Stevelink, B P C Koeleman, J W Sander, et al.Pageof 17